🇺🇸 FDA
Pipeline program

KSV01 Injection

KSV01-R102

Phase 1 small_molecule active

Quick answer

KSV01 Injection for B-ALL is a Phase 1 program (small_molecule) at TScan Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
TScan Therapeutics
Indication
B-ALL
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials